Journal article
Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice
PN Kelly, S Grabow, ARD Delbridge, A Strasser, JM Adams
Blood | AMER SOC HEMATOLOGY | Published : 2011
Abstract
Impaired apoptosis is a cancer hallmark, and some types of lymphomas and other cancers harbor mutations that directly affect key cell death regulators, such as Bcl-2 family members. However, because the majority of tumors seem to lack such mutations, we are examining the hypothesis that tumorigenesis can be sustained at least initially by the normal expression of specific endogenous pro-survival Bcl-2 family members. We previously demonstrated that the lymphomagenesis in Eμ-myc transgenic mice, which constitutively overexpress the c-Myc oncoprotein in B-lymphoid cells and develop pre-B and B-cell lymphomas, does not require endogenous Bcl-2. In striking contrast, we report here that loss in ..
View full abstractGrants
Awarded by National Cancer Institute
Funding Acknowledgements
This work was supported by grants and fellowships from the Cancer Council of Victoria (to P.N.K.), the National Health and Medical Research Council (Program Grant #461221, NHMRC Australia Fellowship), the National Institutes of Health (CA43540), and the Leukemia & Lymphoma Society (SCOR grant #7413). This work was made possible through State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS.